Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 10:47 PM
Study NCT ID:
NCT06847867
Status:
RECRUITING
Last Update Posted:
2025-06-27
First Post:
2025-02-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-21
First Submit QC Date:
None
Study First Post Date:
2025-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-24
Last Update Post Date:
2025-06-27
Last Update Post Date Type:
ACTUAL